CJC-1295 vs Retatrutide for weight loss
Short answer: For weight loss, more users report improvement with CJC-1295 — 100% of 23 reports, versus 92% of 228 for Retatrutide.
CJC-1295 has 0 meta-analyses and 1 randomized trials on PubMed; Retatrutide has 22 and 6.
Based on 354 reports about CJC-1295 and 460 about Retatrutide. Not medical advice.
| CJC-1295 Peptide | Retatrutide Peptide | |
|---|---|---|
| Users say it helped | 57%helped131 reports · high confidence | 76%helped327 reports · high confidence |
| Verdict | Mixed | Mostly positive |
| Research | CResearch: Limited | BResearch: Moderate |
| Meta-analyses / RCTs | 0 / 1 | 22 / 6 |
| Mainly used for | ||
| Weight loss % reporting improvement | 100% (23) | 92% (228) |
| Appetite % reporting improvement | 67% (3) | 73% (86) |
| Energy % reporting improvement | 91% (11) | 69% (75) |
| Sleep % reporting improvement | 80% (44) | 31% (26) |
| Performance % reporting improvement | 96% (23) | 82% (33) |
| Common side effects | flushing, allergic reaction, itching, increased appetite | nausea, fatigue, stomach issues, insomnia |
| Typical dose reported | Not listed | Not listed |
“Within a few weeks on cjc I noticed that I was more full, leaner, and sleep/recover was off the charts. My skin is crazy bright as well.”
This systematic review identifies the state and mechanism of action of emerging pharmacotherapies undergoing or having completed phase 2 and phase 3 clinical trials. The information provided herein furthers the understanding of obesity management, implying direct clinical implications and stimulating research initiatives.
Pharmacol Rev, 2025 ↗“Drastically reduced appetite: At 5mg, I experienced near-total suppression of hunger and cravings. Steady, effortless fat loss: I didn't have to track macros obsessively or do extreme cardio.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate